These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10516371)

  • 1. Iron and cardiac disease in the end-stage renal disease setting.
    Besarab A
    Am J Kidney Dis; 1999 Oct; 34(4 Suppl 2):S18-24. PubMed ID: 10516371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
    Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
    Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of issues relating to iron and infection.
    Fishbane S
    Am J Kidney Dis; 1999 Oct; 34(4 Suppl 2):S47-52. PubMed ID: 10516376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonalcoholic fatty liver disease (NAFLD)--is it a new marker of hyporesponsiveness to recombinant human erythropoietin in patients that are on chronic hemodialysis?
    Orlic L; Mikolasevic I; Lukenda V; Racki S; Stimac D; Milic S
    Med Hypotheses; 2014 Dec; 83(6):798-801. PubMed ID: 25456789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does iron cause bacterial infections in patients with end stage renal disease?
    Cieri E
    ANNA J; 1999 Dec; 26(6):591-6. PubMed ID: 10876474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Erythropoietin-beta in the treatment of anemia in patients with chronic renal insufficiency].
    Dimković N
    Med Pregl; 2001; 54(5-6):235-40. PubMed ID: 11759218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upper limit of serum ferritin: misinterpretation of the 2006 KDOQI anemia guidelines.
    Fishbane S
    Semin Dial; 2008; 21(3):217-20. PubMed ID: 18248518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron overload in the erythropoietin era.
    Robbins KC
    Nephrol Nurs J; 2000 Apr; 27(2):227-31. PubMed ID: 11111550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Iron replacement in hemodialysis patients with a normal serum ferritin level].
    Riedel MK; Morgenstern T
    Dtsch Med Wochenschr; 2004 Sep; 129(36):1849-53. PubMed ID: 15368155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caring for the renal failure patient: optimizing iron therapy.
    Folkert VW; Javier AM; O'Mara NB
    Nephrol Nurs J; 2002 Dec; 29(6):586-93; quiz 594-5. PubMed ID: 12596608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anemia of chronic renal failure: new treatment alternative.
    Seiler S
    CANNT J; 2000; 10(3):35-9, 43-8; quiz 40-2, 49-51. PubMed ID: 11799582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The systemic inflammatory response and its impact on iron nutriture in end-stage renal disease.
    Bistrian BR; Khaodhiar L
    Am J Kidney Dis; 1999 Oct; 34(4 Suppl 2):S35-9. PubMed ID: 10516374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefits of early utilization of intravenous iron.
    Vogel S
    Nephrol Nurs J; 2000 Feb; 27(1):61-5. PubMed ID: 10852693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron requirements in hemodialysis.
    Sargent JA; Acchiardo SR
    Blood Purif; 2004; 22(1):112-23. PubMed ID: 14732819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Appropriate iron supplementation in renal anemia treatment].
    Suzuki M
    Nihon Rinsho; 2004 Jun; 62 Suppl 6():566-8. PubMed ID: 15250370
    [No Abstract]   [Full Text] [Related]  

  • 16. Intravenous iron supplementation for the treatment of anaemia in pre-dialyzed chronic renal failure patients.
    Mircescu G; Gârneata L; Capusa C; Ursea N
    Nephrol Dial Transplant; 2006 Jan; 21(1):120-4. PubMed ID: 16144853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble transferrin receptor is correlated with erythropoietin sensitivity in dialysis patients.
    Daschner M; Mehls O; Schaefer F
    Clin Nephrol; 1999 Oct; 52(4):246-52. PubMed ID: 10543327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of aggressively driven intravenous iron therapy on infectious complications in end-stage renal disease patients on maintenance hemodialysis.
    Bansal A; Sandhu G; Gupta I; Kalahalli S; Nayak R; Zouain E; Chitale RA; Meisels I; Chan G
    Am J Ther; 2014; 21(4):250-3. PubMed ID: 22832501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Results of the explicit health guaranties program to correct anemia of end stage renal disease patients in dialysis].
    González F F
    Rev Med Chil; 2013 May; 141(5):568-73. PubMed ID: 24089270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of iron in patients on chronic dialysis: mistake and misconceptions.
    Sakiewicz P; Paganini E
    J Nephrol; 1998; 11(1):5-15. PubMed ID: 9561479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.